PharmacyCodes



Liometacen [As Meglumine Salt] en es it fr

Categorie

Liometacen [As Meglumine Salt] Les marques, Liometacen [As Meglumine Salt] Analogs

Liometacen [As Meglumine Salt] Les marques melange

  • No information avaliable

    • Liometacen [As Meglumine Salt] Formule chimique

    C19H16ClNO4

    Liometacen [As Meglumine Salt] RX lien

    http://www.rxlist.com/cgi/generic/indometh.htm

    Liometacen [As Meglumine Salt] FDA fiche

    Liometacen [As Meglumine Salt] msds (fiche de securite des materiaux)

    Liometacen_[As_Meglumine_Salt] MSDS

    Liometacen [As Meglumine Salt] Synthese de reference

    Aucune information disponible

    Liometacen [As Meglumine Salt] Poids moleculaire

    357.787 g/mol

    Liometacen [As Meglumine Salt] Point de fusion

    158 oC

    Liometacen [As Meglumine Salt] H2O Solubilite

    0,937 mg / L

    Liometacen [As Meglumine Salt] Etat

    Solid

    Liometacen [As Meglumine Salt] LogP

    3.655

    Liometacen [As Meglumine Salt] Formes pharmaceutiques

    Capsule

    Liometacen [As Meglumine Salt] Indication

    Pour polyarthrite rhumatoïde modérée à grave, y compris des fusées aiguës de maladies chroniques, la spondylarthrite ankylosante, l'arthrose, épaule douloureuse aiguë (bursite et / ou tendinite) et arthrite goutteuse aiguë.

    Liometacen [As Meglumine Salt] Pharmacologie

    L'indométacine, une drogue AINS (AINS) avec des propriétés analgésiques et antipyrétiques, est utilisé pour traiter l'arthrose et la douleur aiguë.

    Liometacen [As Meglumine Salt] Absorption

    Aucune information disponible

    Liometacen [As Meglumine Salt] Toxicite

    Aucune information disponible

    Liometacen [As Meglumine Salt] Information pour les patients

    Indomethacin, like other drugs of its class, is not free of side effects. The side effects of these drugs can cause discomfort and rarely, there are more serious side effects, such as gastrointestinal bleeding, which may result in hospitalization and even fatal outcomes. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) are often essential agents in the management of arthritis, but they also may be commonly employed for conditions which are less serious. Physicians may wish to discuss with their patients the potential risks and likely benefits of NSAID treatment, particularly when the drugs are used for less serious conditions where treatment without NSAIDs may represent an acceptable alternative to both the patient and physician.

    Liometacen [As Meglumine Salt] Organismes affectes

    Les humains et autres mammifères